Healthcare -
Biotechnology - NASDAQ - US
$ 8.32
2.4 %
$ 316 M
Market Cap
14.0
P/E
TRDA - CASH & EQUIVALENTS
Cash & Equivalents TRDA - Entrada Therapeutics, Inc.
101 M
LAST VALUE
49.71%
2 YEAR CAGR
43.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR